A review of prospective Clinical Trials for neurogenic bladder: Pharmaceuticals
Journal Title: Central European Journal of Urology - Year 2014, Vol 67, Issue 3
Abstract
Introduction The neurogenic urinary bladder is defined as a dysfunctional bladder associated with a known neurological injury. We review the data from good quality clinical trials looking at drug therapy for the neurogenic bladder. Materials and methods In order to identify as many prospective trials as possible, we performed Internet searches, using the same search string: Urinary Bladder, neurogenic (MESH). In each case, the search was limited to clinical trial, prospective trial, subjects were human and the language was English. There was no year limit for our search. The next step was duplicate removal, which led to a final number of 580 papers. We defined clear inclusion criteria for the papers. Results A total of 82 full text papers were reviewed and analyzed according to the previously mentioned algorithm. The oldest two prospective clinical trials date back to 1976, with an obvious increase in number of trials each year, reaching more than five trials per year after 2001, which demonstrates increased interest toward the subject. The total number of patients included in the trials is 3904, 888 of which are children. The male: female ratio is close to 1, although there were 9 studies where no information regarding the sex of the patients was available. Conclusions Our analysis stresses the acute need for good quality trials looking at the drugs used for the management of the patients with neurogenic bladders, with adequate statistical power to support the data they present
Authors and Affiliations
Cristian Persu, Emmanuel Braschi, John Lavelle
Keywords
Related Articles
- EP ID EP356358
- DOI 10.5173/ceju.2014.03.art11
- Views 58
- Downloads 0
Chromophobe renal cell carcinoma with sarcomatoid changes: case report and review of literature
Chromophobe renal cell carcinoma (RCC), a subtype of RCC, accounts for 4–6% of all RCC and has better prognosis then conventional RCC. Sarcomatoid dedifferentiation is thought to represent the high–grade end of all subty...
PADAMboom!!!
Editorial.
Management and follow up of extra–adrenal phaeochromocytoma
Introduction The prevalence of phaeochromocytoma (PCC) in patients with hypertension is 0.1–0.6% and about 10% of PCCs are detected in extra–adrenal tissue. The diagnosis and therapy of this rare disease detected as a re...
Clinical and pathological features of metastatic adenocarcinoma of the prostate to the ileum
We present a case of a 74-year-old white male with a history of prostate cancer with unusual metastasis to the ileum, and with ileus as a very unusual first symptom of prostate cancer. This patient presented to us with h...
Effectiveness of combined high–dosed trospium and solifenacin depending on severity of OAB symptoms in elderly men and women under cyclic therapy
in this study. All patients underwent urodynamic examination before enrollment and after the study was completed. For clinical evaluation of LUT state ICIQ-SF questionnaires and bladder diaries were used. Patients with m...